South Africa - 2019 - Health

Management of Rifampicin-Resistant Tuberculosis: A Clinical Reference Guide

Ministry of Health, South Africa

This document defines Drug-resistant tuberculosis (DR-TB) as an active tuberculosis disease caused by Mycobacterium tuberculosis bacilli that are resistant to one or more anti-TB drugs. It outlines the roles of the PCACs and NCAC and provides information on diagnosis.

Process Flow

Compare Versions Please select two versions

Management of Rifampicin-Resistant Tuberculosis: A Clinical Reference Guide Current Version

January 2022

This document defines Drug-resistant tuberculosis (DR-TB) as an active tuberculosis disease caused by Mycobacterium tuberculosis bacilli that are resistant to one or more anti-TB drugs. It outlines the roles of the PCACs and NCAC and provides information on diagnosis.

Request Expert Analysis

Ask one of our policy analysts to take an in-depth look at this policy and provide you with a written summary. An additional cost may apply. Please let us know what questions you are looking to answer.

Thank you for requesting an expert analysis

A member of our team will review your request and reply back to the email address on file.